News ArchivesRead News

Your Weekly Parkinson's News Update for the Week of 5.20.19

Monday May 20, 2019
Study of Treatment for
Cognitive Impairment in Parkinson's
Parkinson's News Today
It is thought that loss of dopamine-producing neurons — a hallmark feature of Parkinson’s — also impairs the bridging function of NMDAneurotransmitter receptors. These proteins, embedded in the membrane of nerve cells, receive signals across the synapse from a previous nerve cell; their impairment can lead to cognitive decline.
By controlling NMDA receptors' activity, the molecule NYX-458 has the potential to rebuild the function of NMDA receptors and reverse cognitive impairment associated with Parkinson’s.
Noninvasive Biomarker for Parkinson's
Possibly Found in EEG Data
Medical Xpress
Researchers suggest that noninvasive EEG readings may provide easily detectable electrophysiological biomarkers to help the diagnosis and fine-tune therapeutic treatments for Parkinson's, with potentially other motor disorders.
Is there a Link between Appendectomies
and Development of Parkinson's?
AJMC Managed Markets Network
“Recent research into the cause of Parkinson’s has centered around alpha synuclein, a protein found in the gastrointestinal tract early in the onset of Parkinson’s,” said Mohammed Sheriff, MD, lead researcher, in a statement. “This is why scientists around the world have been looking into the gastrointestinal tract, including the appendix, for evidence about the development of Parkinson’s.”